A comprehensive view of Cancer. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

California Superior Court rules expert witnesses recruited by plaintiffs in a Zantac lawsuit can testify in case; Zantac maker GSK disagrees with ruling, which may be in conflict with US Federal Court that found Zantac lawsuits are based on flawed science
Published: March 27, 2023 by Daily Mail (London, England)
AstraZeneca to triple its R&D investment in China, hire over 900 R&D personnel in the country; AstraZeneca to offer at least 15 new drugs in Chinese market by 2030, including oncology, respiratory disease, immunization, vaccines, rare disease drugs
Published: March 27, 2023 by ForeignAffairs.co.nz
'Method For Producing Human Professional Antigen-Presenting Cells' in Patent Application Approval Process (USPTO 20230070866)
Published: March 24, 2023 by Cancer Vaccine Daily
Ascend Labs recalls 10 lots of dabigatran etexilate anticoagulant capsules in US after routine test finds suspected carcinogen N-nitroso-dabigatran; products shipped between June 2022 and October 2022
Published: March 23, 2023 by FiercePharma
Merck & Co Submits Chinese Patent Application for Dosing Regimen of Anti-Cd27 Antibodies for Treatment of Cancer
Published: March 23, 2023 by Pharmaceutical Patent News

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count